#HIV & AIDS vaccine
-
No hope for HIV/AIDS vaccine soon: As Johnson & Johnson, Global Partners study shows 25.2% efficacy rate
Investigational vaccine candidate did not provide sufficient protection against HIV infection. No…
Tuesday, 4 Aug 2026
Breaking
